Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01300065 · ClinicalTrials.gov registry record · NA

Evaluation of Two Daily Disposable Contact Lenses.

A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
441
Enrollment target
1
Study location

NCT01300065 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 441 participants, above the 263-participant average among 90 other Myopia trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01300065, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
441 participants
Enrollment target
1
Study location

Study Summary

The objective of this clinical study is to evaluate the product performance of SofLens daily disposable contact lenses packaged in the investigational Test solution versus SofLens daily disposable contact lenses packaged in Control, solution as it relates to comfort when used by subjects who use technology devices (eg, Personal Digital Assistants \[PDAs\], computers, electronic game consoles, hand-held electronic devices, electronic book readers, etc) on an average of 4 hours per day over a week's time for a minimum of 4 days each week.

Conditions Studied

Interventions

  • DEVICE Experimental- Soflens
  • DEVICE Marketed - Soflens

Study Locations (1)

New York

  • Bausch & Lomb Incorporated - Rochester

Trial Details

FieldValue
Enrollment Target 441 participants
Start Date 2011-01
Est. Completion 2011-05
Phase NA

Sponsor

Bausch & Lomb Incorporated

174 total trials

What the Registry Record Tells You About NCT01300065

The ClinicalTrials.gov registry entry for NCT01300065 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 441 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 263-participant average among 90 other Myopia trials with a reported enrollment target (68% higher). The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Experimental- Soflens is the first listed.

NCT01300065 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01300065 about?

NCT01300065 is a clinical study titled "Evaluation of Two Daily Disposable Contact Lenses.". The objective of this clinical study is to evaluate the product performance of SofLens daily disposable contact lenses packaged in the investigational Test solution versus SofLens daily disposable contact lenses packaged in Control, solution as it relates to comfort when used by subjects who use tec...

What is the current status of trial NCT01300065?

This trial is currently completed. It is a NA study. The enrollment target is 441 participants. The study started on 2011-01. Estimated completion is 2011-05.

What conditions does trial NCT01300065 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT01300065?

The interventions under investigation include: Experimental- Soflens (DEVICE), Marketed - Soflens (DEVICE).

Who is sponsoring clinical trial NCT01300065?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01300065 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.